Amneal Pharmaceuticals Inc (AMRX) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Amneal Pharmaceuticals Inc   (NASDAQ: AMRX)


Amneal Pharmaceuticals Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Amneal Pharmaceuticals Inc's ROI in the third quarter of 2026?
Amneal Pharmaceuticals Inc achieved a return on average invested assets (ROI) of 5.59 % in its third quarter of 2026, this is above AMRX's average return on investment of -2.98%.
Amneal Pharmaceuticals Inc s investments during the 12 months ending in the third quarter of 2026 are valued at $3 billion

ROI decreased relative to the period ending Jun 30 2026, due to the decline in net income.

Within the Healthcare sector 126 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 676 to 1202.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM 37.29 % 24.28 % 11.19 % 2.44 % -4.75 %
Y / Y Net Income Change TTM 204.58 % 320.19 % 1059.82 % - 390.07 %
Investment (TTM) in Millions 4,257 2,977 2,676 2,643 2,599
Return On Investment (TTM) 5.59 % 7.91 % 7.19 % 5.34 % 2.52 %
AMRX's Overall Ranking # 1202 # 676 # 969 # 1256 #
Seq. Investment Change TTM 15.22 % 7.96 % 5.3 % 4.81 % 4.31 %
Seq. Net Income Change TTM -18.5 % 18.75 % 41.73 % 122.04 % 12.44 %
Net Income (TTM) in Millions 175 215 181 128 58

AMRX Company Profile >> Back to AMRX Roi Comparisons >> See Annual AMRX Return On Investment



Return On Investment AMRX's Ranking
Within: No.
Industry # 48
Sector # 127
Overall # 1202

Return On Investment Statistics
High Average Low
7.91 %
-2.98 %
-14.34 %
(Jun 30 2026)   (Dec 31 2019)







Financial Statements
Amneal Pharmaceuticals Inc's III. Quarter Investments $ 4,257 Millions AMRX's Balance sheet
Amneal Pharmaceuticals Inc's III. Quarter Income $ -22 Millions Quarterly AMRX's Income Statement
AMRX's Income by Division See AMRX's Income by Division


AMRX Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 2,643 2,203 2,447 2,811 3,279
Y / Y Investment Growth 19.98 % -9.99 % -12.92 % -14.29 % 4.51 %
Net Income in Millions 128 -74 -49 -255 20
Y / Y Net Income Growth - - - - -70.59 %
Annual Return On Investment 4.84 % -3.35 % -1.99 % -9.07 % 0.62 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 4.84 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
AMRX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for AMRX's Competitors
Subscribers only: Roi for Amneal Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for AMRX's Customers

Other Ratios
AMRX's Roa AMRX's Inventory Turnover Ratio AMRX's Growth Rates AMRX's Dividend Statistics
AMRX's Profitability Ratios AMRX's Asset Turnover Ratio AMRX's Dividend Growth
AMRX's Roe AMRX's Valuation Ratios AMRX's Financial Strength Ratios AMRX's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Amgen Inc   13.64 %
Carlisle Companies Incorporated  13.64 %
Bristol myers Squibb Company  13.59 %
3m Company  13.24 %
Beone Medicines Ltd   13.17 %
Regeneron Pharmaceuticals Inc   13.00 %
Abbvie Inc   12.87 %
Lantheus Holdings Inc   11.96 %
Msa Safety Inc  11.78 %
Inspire Medical Systems inc   11.63 %
Transmedics Group Inc   11.55 %
Bioventus Inc   11.26 %
Tenet Healthcare Corp  10.91 %
Bio rad Laboratories Inc   10.59 %
Lemaitre Vascular Inc   10.56 %
Johnson and Johnson  10.53 %
Encompass Health Corporation  10.41 %
Ani Pharmaceuticals Inc  9.61 %
Tactile Systems Technology Inc   9.27 %
Boston Scientific Corporation  9.14 %
Brightspring Health Services Inc   9.01 %
Stryker Corp  8.63 %
Pediatrix Medical Group Inc   8.37 %
Penumbra Inc  8.28 %
Medinotec Inc   8.12 %
Pacific Health Care Organization Inc  8.09 %
Quest Diagnostics Inc  8.01 %
Ge Healthcare Technologies Inc   7.60 %
Incyte Corporation  6.81 %
Merit Medical Systems Inc  6.21 %

Date modified: 2026-11-10T11:46:30+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.